Suptavumab
Suptavumab
Suptavumab (pronounced soo-ptah-voo-mab) is a monoclonal antibody designed for the prevention and treatment of Respiratory Syncytial Virus (RSV) infections.
Etymology
The name "Suptavumab" is derived from the Latin word "supta" meaning "under" and "vumab" is a common suffix for monoclonal antibodies.
Description
Suptavumab is a type of biologic therapy that uses the body's immune system to fight diseases. It is a monoclonal antibody, which means it is made up of identical immune cells that are all clones of a unique parent cell. Suptavumab is designed to bind to a specific protein on the surface of the RSV, preventing the virus from entering human cells and causing infection.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Respiratory Syncytial Virus (RSV): A common respiratory virus that usually causes mild, cold-like symptoms.
- Biologic Therapy: Treatment to boost or restore the ability of the immune system to fight cancer, infections, and other diseases.
See Also
External links
- Medical encyclopedia article on Suptavumab
- Wikipedia's article - Suptavumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski